Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
Abstract Background Uterine Corpus Endometrial Carcinoma (UCEC) is a highly heterogeneous tumor, and limitations in current diagnostic methods, along with treatment resistance in some patients, pose significant challenges for managing UCEC. The excessive activation of G2/M checkpoint genes is a cruc...
Saved in:
Main Authors: | Yiming Liu, Yusi Wang, Shu Tan, Xiaochen Shi, Jinglin Wen, Dejia Chen, Yue Zhao, Wenjing Pan, Zhaoyang Jia, Chunru Lu, Ge Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-025-03667-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma
by: Ru-Gen Liao, et al.
Published: (2025-01-01) -
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma
by: Yanfang Huang, et al.
Published: (2025-01-01) -
Celastrol promotes DNA damage and apoptosis in uterine corpus endometrial carcinoma via promotion of KAT2B-mediated RBPJ acetylation and repression of MCM4 transcription
by: Lipeng Pei, et al.
Published: (2025-02-01) -
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
by: Liang Ma, et al.
Published: (2025-01-01) -
Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature
by: Yong Huang, et al.
Published: (2025-01-01)